Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas (original) (raw)

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kamen BA, Eibl B, Cashmore AR, Bertino JR: Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-(3,4,5-trimethoxyanilino) methyl] quinazoline), a nonclassical antifolate in methotrexate-resistant leukemia cells in vitro. Biochem Pharmacol 33:1697–1699, 1984
    Google Scholar
  2. Jackson RC, Leopold WR, Hamelehle KL, Fry DW: Preclinical studies with trimetrexate: A review of conclusions and unanswered questions. Semin Oncol 15 (2 Suppl 2):1–7, 1988
    Google Scholar
  3. Lathan B, Von Hoff DD, Elslager E: Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone. Cancer Treat Rep 68:733–738, 1984
    Google Scholar
  4. Steward JA, McCormack JJ, Tong W, DeLap RJ, Grillo-Lopez AJ: A phase I study of trimetrexate. (Abstract) Proc Am Assoc Cancer Res 26:159, 1985
    Google Scholar
  5. Rosen M, Ohnuma T, Zimet A, Coffey V, Zhang N, Holland JF: Phase I study of trimetrexate (trimetrexate, TMQ, JB-11) glucuronate in a 5 day infusion schedule. (Abstract) Proc Am Assoc Cancer Res 27:172, 1986
    Google Scholar
  6. Stewart JA: Safety and tolerance of trimetrexate: Results of a phase II multicenter study in patients with metastatic cancer refractory to conventional therapy or for which no conventional therapy exists. Semin Oncol 15 (2 Suppl 2):10–16, 1988
    Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Stanford University, 94305, Stanford, CA, USA
    Robert W. Carlson
  2. Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 91010, Duarte, CA, USA
    James H. Doroshow & Oluwole O. Odujinrin
  3. San Joaquin Valley Community Clinical Oncology Program, 93715, Fresno, CA, USA
    Marshall S. Flam
  4. Northern California Cancer Center, 94002, Belmont, CA, USA
    Robert W. Carlson, Mary Malec & Kathleen R. Lamborn

Authors

  1. Robert W. Carlson
  2. James H. Doroshow
  3. Oluwole O. Odujinrin
  4. Marshall S. Flam
  5. Mary Malec
  6. Kathleen R. Lamborn

Rights and permissions

About this article

Cite this article

Carlson, R.W., Doroshow, J.H., Odujinrin, O.O. et al. Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas.Invest New Drugs 8, 387–389 (1990). https://doi.org/10.1007/BF00198597

Download citation

Key words